Literature DB >> 22911150

The results of a surgical complication protection program (BLIS, Inc.) for private pay bariatric patients in the U.S.: 2006-2011.

Joseph E Chebli1, Regi Schindler.   

Abstract

BACKGROUND: Bariatric surgery is the most effective treatment for morbid obesity and associated medical co morbidities. There is currently minimal surgical treatment penetration of this widespread disease. BLIS has been able to improve the access to bariatric surgery for cash-pay patients by alleviating concern about the costs of post-surgical complications. Recently, there has become an ability to attract payor groups by offering a "bundled" payment which includes BLIS complication protection.
METHODS: A total of 5,364 self-pay patients underwent laparoscopic adjustable gastric banding, laparoscopic vertical sleeve gastrectomy, or laparoscopic Roux-en-Y gastric bypass with BLIS complication insurance.
RESULTS: Of the overall 5,364 patients, the 30-day mortality rate was 0.04 % and 1-year mortality rate was 0.06 %. The frequency of complications was 5.4 % in the gastric banding group, 6.5 % in the sleeve gastrectomy group, and 9.7 % in the gastric bypass group.
CONCLUSIONS: The results for mortality and complications in the BLIS data set compares very well with other large data sets in bariatric surgery. BLIS complication insurance improves the access to bariatric surgery in patients who self-pay.

Entities:  

Mesh:

Year:  2012        PMID: 22911150     DOI: 10.1007/s11695-012-0745-6

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  8 in total

1.  Baseline data from American Society for Metabolic and Bariatric Surgery-designated Bariatric Surgery Centers of Excellence using the Bariatric Outcomes Longitudinal Database.

Authors:  Eric J DeMaria; Virginia Pate; Michael Warthen; Deborah A Winegar
Journal:  Surg Obes Relat Dis       Date:  2010-01-04       Impact factor: 4.734

2.  Bariatric surgery: an IDF statement for obese Type 2 diabetes.

Authors:  J B Dixon; P Zimmet; K G Alberti; F Rubino
Journal:  Surg Obes Relat Dis       Date:  2011-06-01       Impact factor: 4.734

3.  Long-term mortality after gastric bypass surgery.

Authors:  Ted D Adams; Richard E Gress; Sherman C Smith; R Chad Halverson; Steven C Simper; Wayne D Rosamond; Michael J Lamonte; Antoinette M Stroup; Steven C Hunt
Journal:  N Engl J Med       Date:  2007-08-23       Impact factor: 91.245

4.  Socioeconomic disparities in eligibility and access to bariatric surgery: a national population-based analysis.

Authors:  Matthew Martin; Alec Beekley; Randy Kjorstad; James Sebesta
Journal:  Surg Obes Relat Dis       Date:  2009-07-17       Impact factor: 4.734

5.  Prevalence and trends in obesity among US adults, 1999-2008.

Authors:  Katherine M Flegal; Margaret D Carroll; Cynthia L Ogden; Lester R Curtin
Journal:  JAMA       Date:  2010-01-13       Impact factor: 56.272

Review 6.  Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis.

Authors:  Henry Buchwald; Rhonda Estok; Kyle Fahrbach; Deirdre Banel; Michael D Jensen; Walter J Pories; John P Bantle; Isabella Sledge
Journal:  Am J Med       Date:  2009-03       Impact factor: 4.965

7.  Perioperative safety in the longitudinal assessment of bariatric surgery.

Authors:  David Reed Flum; Steven H Belle; Wendy C King; Abdus S Wahed; Paul Berk; William Chapman; Walter Pories; Anita Courcoulas; Carol McCloskey; James Mitchell; Emma Patterson; Alfons Pomp; Myrlene A Staten; Susan Z Yanovski; Richard Thirlby; Bruce Wolfe
Journal:  N Engl J Med       Date:  2009-07-30       Impact factor: 91.245

8.  Effects of bariatric surgery on mortality in Swedish obese subjects.

Authors:  Lars Sjöström; Kristina Narbro; C David Sjöström; Kristjan Karason; Bo Larsson; Hans Wedel; Ted Lystig; Marianne Sullivan; Claude Bouchard; Björn Carlsson; Calle Bengtsson; Sven Dahlgren; Anders Gummesson; Peter Jacobson; Jan Karlsson; Anna-Karin Lindroos; Hans Lönroth; Ingmar Näslund; Torsten Olbers; Kaj Stenlöf; Jarl Torgerson; Göran Agren; Lena M S Carlsson
Journal:  N Engl J Med       Date:  2007-08-23       Impact factor: 91.245

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.